Presently, James M. Rolke is Chief Executive Officer & Director at Revelation Biosciences, Inc. and Chief Executive Officer & Director at Revelation Biosciences Sub, Inc. (a subsidiary of Revelation Biosciences, Inc.).

He is also on the board of Revelation Therapeutics LLC.

In the past Mr. Rolke occupied the position of Chief Scientific Officer for La Jolla Pharmaceutical Co., Associate Scientist at Alpha-Beta Technology, Inc., Manager-Process Development at Glycogenesys, Inc., Associate Director-Pharmaceutical Development at Mersana Therapeutics, Inc., Operations Director at Prospect Therapeutics, Inc., Principal Scientist at Surgical Sealants, Inc., Scientist at Geltex, Inc. and Chief Technology Officer for Pluromed, Inc.

He received an undergraduate degree from Keene State College.